Repligen Corp. (NASDAQ: RGEN) to Hold Q4 2009 Earnings Conference Call on June 11

Repligen Corporation (NASDAQ: RGEN) will be holding a Q4 2009 earnings conference call for investors on Thursday, June 11, 2009 at 10:00 a.m. ET.

Interested parties can also listen to the live broadcast by dialing (800) 295-4740 (U.S.) or 617) 614-3925 (International). A live webcast of the conference call will be available on Repligen Corp.’s website at http://www.repligen.com. An archive of the audio webcast will be available shortly after the call and may be accessed at www.repligen.com.

Repligen Corporation (NASDAQ: RGEN) is a biopharmaceutical company focused on the development of novel therapeutics for neurological disorders. In addition, we are the world's leading supplier of recombinant Protein A, the sales of which partially fund the advancement of our development pipeline while supporting our financial stability. Repligen's corporate headquarters are located at 41 Seyon Street, Building #1, Suite 100, Waltham, MA 02453.

Click here for more Business News 

About The Global Market Directory (TheGMD) 

TheGMD provides an online global directory listing featuring public companies, stock brokers, brokerage firms and individuals.  The GMD provides profiles for Brokerage Firms, Stock Brokers and Individuals in addition to Public Companies. 

The GMD is a division of TransWorldNews, Inc. Companies can utilize the TransWorldNews press release distribution services and have all news releases attached to their GMD profile.

Create your profile on The Global Market Directory.